Abstract Global Strategy for the Diagnosis, Management, and Prevention of COPD 2018 is a
consensus report published periodically since 2001 by an international panel of health …

As the third leading cause of death in the United States in 2014, chronic obstructive
pulmonary disease (COPD) presents a significant challenge to the health care provider. 1 …

Rationale: Single-center randomized controlled trials of the Zephyr endobronchial valve
(EBV) treatment have demonstrated benefit in severe heterogeneous emphysema. This is …

Rationale: This is the first multicenter randomized controlled trial to evaluate the
effectiveness and safety of Zephyr Endobronchial Valve (EBV) in patients with little to no …

Das vorliegende Dokument ist eine Neufassung und Aktualisierung der Leitlinie zur
Diagnostik und Therapie von Patienten mit COPD, die die bisherige Version aus dem Jahr …

Endoscopic lung volume reduction (ELVR) is being adopted as a treatment option for
carefully selected patients suffering from severe emphysema. ELVR with the one-way …

Rationale: Less invasive, nonsurgical approaches are needed to treat severe emphysema.
Objectives: To evaluate the effectiveness and safety of the Spiration Valve System (SVS) …

For over 150 years, bronchoscopy, especially flexible bronchoscopy, has been a mainstay
for airway inspection, the diagnosis of airway lesions, therapeutic aspiration of airway …

Endoscopic lung volume reduction (ELVR) therapies are gaining prominence as a treatment
option with guideline recommendations by COPD GOLD and NICE and the recent FDA …

Background Lung volume reduction surgery (LVRS) and bronchoscopic lung volume
reduction (BLVR) with endobronchial valves can improve outcomes in appropriately …